Could a quick blood thinner before stroke surgery boost recovery?
NCT ID NCT07135089
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether giving the blood-thinning drug tirofiban before a clot-removal procedure helps people recover better after a stroke caused by a blocked artery. About 870 adults with a large-vessel stroke will receive either tirofiban or a placebo before the procedure. The main goal is to see if more people can live independently 90 days later.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
tirofiban (a blood-thinning drug given intravenously)
What this could lead to
If it works, this could provide a new way to reduce disability after stroke by giving a clot-preventing drug right before the clot-removal procedure.
What could go wrong
This is a large phase 3 trial, but it is still testing an unproven approach. The drug may increase bleeding risk, and the benefit may be small or not apply to all stroke patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STROKE, ISCHEMIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
General Hospital of Northern Theater Command
RECRUITINGShenyang, Liaoning, 110016, China
Contact Phone: •••-•••-•••• Email: •••••@•••••